Schedule 13G ownership disclosure

MARINUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 56854Q200

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,959,161
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000053417-24-000021
Form type
SC 13G
Filer
JENNISON ASSOCIATES LLC
CIK
CIK 53417
Filed
Feb 08, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub